RQ Bio

RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.

Health and bio

Funding rounds

1. June 24, 2026
   Series A · $115M
   FFrazier Life Sciences (lead), EEQT Life Sciences, FForbion Capital Partners, LLifeArc Ventures, MMonograph Capital, OOxford Science Enterprises, UUniversity of Oxford, WWellington Management
   Source: fundraisingfox.com
2. April 7, 2021
   Website created

Founders and team

• JO
  Jane Osbourn Founder

  LinkedIn
• MW
  Mike Westby Founder

  LinkedIn
• PK
  Paul Kellam Founder

  LinkedIn
• VW
  Vicky Wheeler Senior Director and Head of Programme Management
• BN
  Bradley Norton Vice President
• DN
  Debra Nevin Vice President
• GK
  Gavin Koh Chief Medical Officer

Investors

• EEQT Life Sciences
• FForbion Capital Partners
• FFrazier Life Scienceslead investor
• LLifeArc Ventures
• MMonograph Capital
• OOxford Science Enterprises
• UUniversity of Oxford
• WWellington Management

Companies like RQ Bio

• UUpstream BiotechnologySeed · Jul 2026
• CCentivax$45M Series A · Jul 2025
• MMemo Therapeutics$22M Series B+ · May 2024
• KKopra BioSeed · Jun 2026
• PPaldara
• EEstuary Biotherapeutics$103M Series A · Oct 2026

Other companies backed by Frazier Life Sciences

• IImmutrin$86.45M Series A · Mar 2026
• AAngitia Bio$130M Series B+ · Feb 2026
• AAirNexis Therapeutics$200M Series A · Jan 2026
• AAspen Neuroscience$115M Series B+ · Nov 2025
• TTubulis$360M Series B+ · Oct 2025
• AAlpha-9 Oncology$175M Series B+ · Oct 2024

Frazier Life Sciences portfolio →